Article ID Journal Published Year Pages File Type
5565242 Complementary Therapies in Medicine 2017 11 Pages PDF
Abstract
The available evidence from present study supported but limited to recommend the routine use of CHM adjuvant therapy for MS because of the poor methodological quality and clinical heterogeneity. However, we identified an area that is worthy of further study. Furthermore, we selected high frequent use of CHMs as a promising candidate for further clinical application and MS trials. Further rigorous randomized-controlled trials are needed.
Related Topics
Health Sciences Medicine and Dentistry Complementary and Alternative Medicine
Authors
, , , , , , , , ,